GKB Ophthalmics LTD.
Gkb Ophthalmics Ltd. (GKB): company summary
The company's business has improved significantly, with annual revenue rising 36.8% to ₹149 crore and net profit swinging from a loss of ₹7 crore to a profit of ₹3 crore.
Gkb Ophthalmics Ltd. (GKB) is a micro-cap Healthcare company valued at ₹32 crore operating in Medical Equipment & Supplies on the NSE and BSE.
- Recent price move
- Gkb Ophthalmics Ltd. last traded at ₹67.4, sharply up 5.30% on the day.
- Recent developments
- On 2026-09-30, promoter holding was reported at 51.15%, indicating no significant change in ownership. On 2026-06-30, the company reported a net profit of ₹2 crore for the latest quarter, marking a turnaround from a net loss in the same quarter the previous year.
- Financial performance
- The company's business has improved significantly, with annual revenue rising 36.8% to ₹149 crore and net profit swinging from a loss of ₹7 crore to a profit of ₹3 crore. However, the latest quarter showed revenue growth of only 2.3% compared to the same quarter a year earlier, while net profit swung from a loss of ₹1 crore to a profit of ₹2 crore.
- Valuation multiples
- The stock trades at 27.9 times earnings, broadly in line with the Healthcare median of 32.0, 0.62 times book value.
- Things to watch
- The stock is 15.9% below its 52-week high, and the company's net profit margin remains low at 2.0%. The return on equity is also low at 2.3%, suggesting limited profitability relative to equity.
- Where it stands
- GKB Ophthalmics Limited has shown strong revenue growth over the past three years, but its profitability remains limited. The latest quarter marked a significant improvement in net profit, but the stock is still far below its recent high. The company's return on equity and net profit margin indicate ongoing challenges in generating returns for shareholders.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by valuation (6.5), but held back by quality (0.8).
DocStoX score
Low confidenceAt a glance
Key highlights
- Revenue compounding 48% a year
- Low leverage — D/E 0.22
- Profit shrinking 14% a year
- Loss-making in some of the last 5 years
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Medical Equipment & Supplies
Explore GKB OPHTHALMICS LTD.’s valuation
Free deep-dive tools · no sign-up
GKB OPHTHALMICS LTD. peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare GKB OPHTHALMICS LTD. with peers
Related tools & concepts
Value GKB OPHTHALMICS LTD. with the ratios and calculators DocStoX uses in its analysis.

